Application — Other
CereGate: freezing-of-gait therapy software clinical investigation
Device
No device entry covers this hardware yet. The spec card below lists what the source says.
Lab or organization
CereGate freezing-of-gait clinical investigation
CereGate (Munich) is a clinical-stage neurotechnology company whose approach is software, not new hardware: its therapy software runs on existing Boston Scientific deep brain stimulation (DBS) systems and is currently in clinical investigation.
- first clinical indication: freezing of gait (FoG), a sudden interruption of walking that persists in some Parkinson’s patients despite optimized medication and responds poorly to established DBS
- separately, the company conducts research in spinal cord stimulation
Clinical readouts have not been published in the sources used here.